Screening of placenta accreta spectrum disorder using maternal serum biomarkers and clinical indicators: a case–control study

Screening of placenta accreta spectrum disorder using maternal serum biomarkers and clinical indicators: a case–control study

Abstract Background Placenta accreta spectrum (PAS) disorder is a major cause of postpartum hemorrhage-associated maternal and fetal death, and novel methods for PAS screening are urgently needed for clinical application. Methods The purpose of this study was to develop new methods for PAS screening...

Full description

Bibliographic Details
Main Authors: Jiayi Zhou, Si Yang, Xingneng Xu, Xiuting Xu, Xuwei Wang, Anqi Ye, Yanhong Chen, Fang He, Bolan Yu
Format: Article
Language:English
Published: BMC 2023-07-01
Series:BMC Pregnancy and Childbirth
Subjects:
Screening model
Placenta accreta spectrum
Biomarkers
Online Access:https://doi.org/10.1186/s12884-023-05784-2

Internet

https://doi.org/10.1186/s12884-023-05784-2

Similar Items